Charles Russell Speechlys advises Iceni Capital and other selling shareholders on the sale of StockWell Communications
Charles Russell Speechlys has advised Iceni Capital and other selling shareholders of StockWell Communications, the international strategic communications and reputation management firm, on its sale to Teneo Holdings.
Following its acquisitions of StockWell and Blue Rubicon, Teneo will be one of the largest strategic communications practices in the European market.
All members of StockWell’s senior management team, including Managing Partners Tim Burt, Philip Gawith and Richard Holloway, will continue as part of the Teneo leadership team.
The Charles Russell Speechlys team was led by Private Equity Partner Andrew Clarke and Private Equity Senior Associate Richard Coleman.
Commenting on the transaction, Julian Hanson-Smith, the Chairman of StockWell Communications, said: “Andrew and Richard have advised StockWell Communications and its shareholders since its inception in 2010…The team at Charles Russell Speechlys again provided the vendor shareholders with valuable guidance and support throughout the transaction process, and managed to balance the interests of all parties. "
News & Insights
Charles Russell Speechlys advises Civica Group on acquisition of Electoral Reform Services
Charles Russell Speechlys has advised longstanding client, the Civica Group on its latest acquisition of Electoral Reform Services Limited.
Charles Russell Speechlys advises the founders of Charterhouse Voice & Data Plc on strategic investment by August Equity LLP
Charterhouse, is a multi-award winning provider of voice communication, data, hosting and cyber security to mid and large tier customers.
Charles Russell Speechlys advises on the investment into TrustedHousesitters by Rockpool
Charles Russell Speechlys advise TrustedHousesitters on significant investment into the company by private equity firm Rockpool Investments
Kiadis Pharma secures €20 million debt financing facility from Kreos Capital
Charles Russell Speechlys advises Kreos Capital V Ltd on additional growth capital investment of €20 million in Kiadis Pharma NV